AI Eye Podcast 498: GBT Developing Expert System For qTerm Device, Predictiv AI Donates ThermalPass Fever Detection System
#AIEye #Podcast #498: GBT (OTCPINK: $GTCH) Developing Expert System for qTerm Device, Predictiv AI (TSXV: $PAI.V) Donates ThermalPass Fever Detection System; #Artificialintelligence
Global #AI in Drug Development and Discovery to Reach $4.815 Billion by 2027
Point Roberts WA, Vancouver BC – December 17, 2020 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence(AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).
Listen to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2020/121720-AI-Eye.mp3
Read this in full at AI Eye Podcast #498: GBT Developing Expert System for qTerm Device, Predictiv AI Donates ThermalPass Fever Detection System
Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (OTCPINK:OTCPK:GTCH) (TSXV:PAI)
GBT Tokenize Corp., the joint venture of GBT Technologies Inc. (OTC PINK:GTCH), is developing an expert system – an artificial intelligence based computer program that solves problems that would usually require a human expert – based flow for its qTerm device mobile application. The aim of this, according to the press release, “will be to integrate machine learning functions to allow the expert system to acquire more and more knowledge from past experience and various external sources.” Danny Rittman, GBT's CTO, explained:
"We are preparing qTerm infrastructure for our qTerm vitals device and our goal is to develop an advanced flow for its mobile application. The mobile application flow is targeted to work with a backend server and together to run an expert system that will use a knowledge database and an inference engine. We believe that our qTerm device will become a health monitor device for users, enabling health-aware life. We believe this type of system can save lives for users with existing conditions.”
Predictiv AI Inc. (TSXV:PAI) has donated one of its ThermalPass fever detection systems to the Flemingdon Food Bank in Ontario, Canada, to “help keep patrons, staff, and volunteers, healthy and safe as demand for food banks continues to increase amid this busy and challenging holiday season.” Michael Lende, President and CEO of Predictiv AI, commented:
"ThermalPass can play an important role in the health and peace of mind of patrons, volunteers, and staff as it identifies individuals with an elevated temperature accurately and efficiently. Predictiv AI is proud to do our part in helping support the community during these difficult times."
Global AI in Drug Development and Discovery to Reach $4.815 Billion by 2027
A report published by Allied Market Research finds that the global AI in Drug Development and Discovery market will grow from $520 million in 2019 to $4.815 billion by 2027 with a compound annual growth rate (OTC:CAGR) of 31.6 percent in the forecast period 2020-2027. An excerpt from the report overview outlines the role of AI in the market:
Artificial intelligence has significant applications in the drug discovery field as it helps track diseases, create disease cures and predict which animal viruses appear to mutate. Artificial intelligence has been known to enhance R&D in drug discovery, which has helped researchers to discover chronic disease treatments. Drug discovery and development in the fields of medicine, pharmacology, and biotechnology are processes for the creation, design, and procurement of a drug through identifying a biological target, such as enzyme protein, gene, or receptor. Previously, the drugs were discovered by identifying the active ingredient conventional treatments. Thus, drug discovery is the first step in the process of identifying potential novel drugs and their medicinal purpose. New criteria for drugs are measured based on their bioavailability, efficacy, potency, and toxicity.
Sam Mowers, Investorideas.com
Read and hear other editions of the AI Eye
For a list of artificial intelligence stocks on Investorideas.com visit here
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About GBT Technologies Inc.
GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (GBT TECHNOLOGIES) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms. GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. GBT’s system envisions the creation of a global mesh network. The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles,podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns :Crypto Corner ,Play by Play sports and stock news column,Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change ,Exploring Mining theAI Eye .
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: InvestorIdeas - Disclaimer, full disclosure, compensation disclosure Learn more about publishing your news release and our other news services on the Investorideas.com
Disclosure GTCH is a paid featured ai stock on investorideas
newswire Investorideas.com Stock News, Newswire, press release, social media and ticker tag articles services for TSX stocks, CSE.com stocks, NYSE stocks, NASDAQ stocks, OTC stocks and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: InvestorIdeas.com - Privacy Policy
The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitterhttps://twitter.com/Investorideas
Follow us on FacebookLog into Facebook
Follow us on YouTubeInvestorIdeas.com - news that inspires big ideas
Download ourMobile App for iPhone and Android
Join our Investor ClubJoin Investorideas.com and get investing podcasts and ideas for cannabis, cleantech and climate change, artificial intelligence, crypto and blockchain, vegan, mining, and esports stocks
Contact Investorideas.com
800 665 0411
Get more Technology stock investor ideas - news, articles, podcasts and stock directories
Analyst's Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com Disclosure GTCH is a paid featured ai stock on investorideas newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.